LPS pretreatment of mouse peritoneal macrophages differentially modulates TNFα and iNOS expression

Many studies have established that pretreatment of mouse macrophages with LPS will alter subsequent responsiveness of these cells to stimulation either with LPS or other stimuli. Incubation of C3Heb/FeJ mouse macrophages with low sub-stimulatory (e.g. 0.10 ng/ml) LPS for 6 h, followed by activation with 100 ng/ml of LPS results in up-regulation of LPS-dependent TNFα production and suppression of the ability of these cells to secrete nitric oxide (NO). To assess whether these two responses might be co-ordinately regulated, immunocytochemical analyses of LPS-pretreated macrophages were carried out using anti-TNFα and anti-iNOS antibodies, both with and without a period of LPS pretreatment. As anticipated, the detection of individual iNOS-expressing macrophages in LPS-stimulated cultures accurately reflected threshold doses of LPS required for detection of NO in culture supernatants in terms of frequency of percentage of the total population positive for expression of iNOS protein. Pretreatment with sub-stimulatory doses of LPS significantly reduced the frequency of these iNOS-expressing macrophages responsive to subsequent LPS stimulation, supporting the concept of iNOS down-regulation at the pretranslational level. In contrast, the detection of TNFα-expressing macrophages in LPS-stimulated cultures did not correlate directly with the detection of TNFα in culture supernatants. Further, pretreatment with sub-stimulatory doses of LPS did not always correlate with the frequency of TNFα-expressing cells in response to LPS treatment. These results support the concept that different regulatory mechanisms may be operative in differential regulation of macrophage TNFα and NO responsiveness by pretreatment of macrophages with sub-stimulatory doses of LPS.

Population dynamics of inducible nitric oxide synthase production by LPSand LPS/IFNγ-stimulated mouse macrophages

The reactive nitrogen intermediate, nitric oxide (NO) is important in host defense against both NO-sensitive microorganisms and tumor cells. Macrophages are one of the chief inflammatory sources, especially when stimulated with the combination of LPS and interferonγ (IFNγ). It is not known, however, whether IFNγ-mediated augmentation of LPS-induced production of NO is the result of greater production by all cells or to the recruitment of more producer macrophages within a given population. This question was addressed, first, by stimulating mouse macrophages (either bone marrow culture-derived, inflammatory peritoneal or those of the cell line, RAW 264.7) with up to 10 U/ml IFNγ for as long as 24 h. Under these conditions, there was little or no production of NO and rare or no cells were immunocytochemically positive for the inducible form of nitric oxide synthase (iNOS), which catalyzes the production of NO. Populations similarly exposed to 1 ng/ml LPS were low producers of NO and contained somewhat more, but still only a few (< 15%), iNOS-positive cells. In contrast, as the concentration of IFNγ was increased (≥ 1 U/ml) in the presence of a constant amount of LPS (1 ng/ml), the principal effect was to increase both the production of NO and the number of iNOS-positive macrophages. The amount of iNOS expressed by some cells also appeared to be increased. Two important conclusions can be drawn from these findings: (1) there is heterogeneity in mouse macrophage populations with respect to the production of iNOS; and (2) increasing concentrations of IFNγ appear to augment LPS-induced secretion of NO by recruiting increasingly greater numbers of macrophages into the production of iNOS. Such results potentially provide important clues as to how IFNγ may be acting at the subcellular level to enhance iNOS synthesis.

Both basal and enhancer κB elements are required for full induction of the mouse inducible nitric oxide synthase gene

The transcriptional regulatory region of the mouse inducible nitric oxide synthase (iNOS) gene has two KB elements, one enhancer-linked (KBII) and the other (KBI) proximal to its core promoter. Mutation of κBII substantially reduced the extent to which the iNOS promoter could be induced by LPS and interfered with augmented responsiveness of the promoter to LPS+IFN-γ. Mutation of KBI had a quantitatively less dramatic negative effect on LPS responsiveness and this construct still showed augmented responsiveness to LPS+IFN-γ. When both KB elements were mutated, inducibility by LPS and, in particular, by LPS+IFN-γ was paradoxically restored, compared with the mutated KBII alone, suggesting cooperative interactions among the transcription factors that trans-activate the iNOS gene. In vivo footprint analysis showed that both KB elements were bound by protein complexes when macrophages were stimulated with LPS ± IFN-γ. Furthermore, KBI was bound even in untreated cells, suggesting that KB binding proteins might also have a negative influence on expression of the gene. Both KBI and KBII were bound by NF-KB/Rel proteins found in nuclear extracts prepared from macrophages treated with LPS ± IFN-γ, although the specificity of binding to each element was different. Our results show that, while NF-KB/Rel proteins are required for maximal expression of the iNOS gene, alone they are not alone sufficient. Furthermore, the results reported here show that the augmentative effect of IFN-γ on the LPS-induced expression of the iNOS gene is not mediated through increased activation of NF-KB/Rel.

Generation of diversity in the innate immune system: macrophage heterogeneity arises from gene-autonomous transcriptional probability of individual inducible genes

Microbial products such as LPS stimulate macrophages to produce a wide diversity of inducible gene products needed for immediate host defense and priming of an appropriate acquired immune response. In this study, we have examined LPS-inducible gene expression in subclones of a mouse macrophage cell line, RAW264, using cDNA microarrays. Even archetypal target genes such as TNF-alpha were not induced in all subclones, and there was no absolute correlation between expression of pairs of genes. Nevertheless, the array analysis revealed clusters of genes that were more likely to be coexpressed. RAW264 cells stably transfected with luciferase reporter genes driven by LPS-responsive promoters revealed the same kind of clonal heterogeneity. The results indicate that each LPS-inducible gene has its own inherent probability of activation in response to LPS.

Autocrine/Paracrine IFN-αβ Mediates the Lipopolysaccharide-Induced Activation of Transcription Factor Stat1α in Mouse Macrophages: Pivotal Role of Stat1α in Induction of the Inducible Nitric Oxide Synthase Gene

We have examined the role of Stat1α in the induction by LPS of the mouse inducible nitric oxide synthase (EC 1.14.13.39) gene. LPS induced both the tyrosine phosphorylation of Stat1α and the production of nitric oxide in a time- and dose-dependent manner. The phosphorylation of Stat1α elicited by LPS differed from that observed using IFN-γ or IFN-β, in that LPS induced less phosphorylated protein and the time course of induction was much delayed (2–4 h compared with 30 min). Cycloheximide inhibited LPS-mediated Stat1α phosphorylation. In addition, cell culture supernatants derived from macrophages treated with LPS for 4 h could be transferred to naive macrophage cultures resulting in rapid (30 min), rather than delayed (4 h), phosphorylation of Stat1α. Together, these results implicated an autocrine/paracrine effector protein(s) in the phosphorylation process. LPS stimulated phosphorylation of Stat1α in peritoneal macrophages derived from IFN-γ-knockout mice, negating any possibility that IFN-γ was the mediator. By contrast, neutralizing Ig raised against mouse IFN-αβ inhibited both the delayed LPS-mediated phosphorylation of Stat1α and the rapid induction of phosphorylation induced by supernatants from LPS-stimulated cultures. Collectively, these results show that LPS-induced IFN-αβ production, Stat1α activation, and nitrite accumulation closely parallel one another, suggesting that indirect activation of transcription factor Stat1α by IFN-αβ is a critical determinant of LPS-mediated inducible nitric oxide synthase gene expression.

An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide

Mouse macrophages can be stimulated by interferon (IFN)-gamma and bacterial lipopolysaccharide (LPS) to produce nitric oxide (NO) as the result of expression of the inducible NO synthase (iNOS; EC 1.14.13.39) gene. The iNOS gene promoter contains a candidate gamma-interferon-activated site (GAS). In transfection studies reported here, it was demonstrated that a luciferase reporter-gene construct, containing four synthetic copies of the iNOS GAS, was inducible when transfected macrophages were stimulated with either IFN-gamma, LPS, or a combination of the two. Consistent with this finding were other transfection analyses, which showed that responsiveness of the intact iNOS promoter to these same agents was significantly reduced when two conserved nucleotide positions within the GAS were mutated. Oligonucleotide probes, which mimicked the iNOS GAS, formed a complex with proteins that appeared in the nuclei of IFN-gamma or IFN-gamma + LPS-treated macrophages within 30 min of stimulation, as shown by electrophoretic mobility shift assay. LPS alone also caused the the appearance of a nuclear protein capable of binding the iNOS GAS-containing oligonucleotide; however, in contrast to binding induced by IFN-gamma, approximately 2 h of stimulation with LPS were required. The protein bound to the iNOS GAS-containing oligonucleotide reacted specifically with an antibody raised against Stat1a, regardless of the stimulus used. These data collectively support the conclusion that binding of Stat1 alpha to the iNOS promoter's GAS is required for optimal induction of the iNOS gene by IFN-gamma and LPS.